Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global High Affinity Nerve Growth Factor Receptor Market Growth (Status and Outlook) 2022-2028

  • LP 4923110
  • 112 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of High Affinity Nerve Growth Factor Receptor will have significant change from previous year. According to our (LP Information) latest study, the global High Affinity Nerve Growth Factor Receptor market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global High Affinity Nerve Growth Factor Receptor market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States High Affinity Nerve Growth Factor Receptor market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global High Affinity Nerve Growth Factor Receptor market, reaching US$ million by the year 2028. As for the Europe High Affinity Nerve Growth Factor Receptor landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main High Affinity Nerve Growth Factor Receptor players cover Array BioPharma Inc, Astellas Pharma Inc, AstraZeneca Plc, and Daiichi Sankyo Co Ltd, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of High Affinity Nerve Growth Factor Receptor market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

ASP-7962

AZD-7451

BNN-27

Cenegermin

CRB-0089

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Bile Duct Cancer

Papillary Thyroid Cancer

Low Back Pain

Lung Cancer

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Array BioPharma Inc

Astellas Pharma Inc

AstraZeneca Plc

Daiichi Sankyo Co Ltd

Dompe Farmaceutici SpA

Genzyme Corp

Handok Inc

Ignyta Inc

Loxo Oncology Inc

Merck & Co Inc

Nerviano Medical Sciences Srl

Plexxikon Inc

Proximagen Ltd

Rottapharm Biotech Srl

Sienna Biopharmaceuticals Inc

Tiziana Life Sciences Plc

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global High Affinity Nerve Growth Factor Receptor Market Size 2017-2028

2.1.2 High Affinity Nerve Growth Factor Receptor Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 High Affinity Nerve Growth Factor Receptor Segment by Type

2.2.1 ASP-7962

2.2.2 AZD-7451

2.2.3 BNN-27

2.2.4 Cenegermin

2.2.5 CRB-0089

2.2.6 Others

2.3 High Affinity Nerve Growth Factor Receptor Market Size by Type

2.3.1 High Affinity Nerve Growth Factor Receptor Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global High Affinity Nerve Growth Factor Receptor Market Size Market Share by Type (2017-2022)

2.4 High Affinity Nerve Growth Factor Receptor Segment by Application

2.4.1 Bile Duct Cancer

2.4.2 Papillary Thyroid Cancer

2.4.3 Low Back Pain

2.4.4 Lung Cancer

2.4.5 Others

2.5 High Affinity Nerve Growth Factor Receptor Market Size by Application

2.5.1 High Affinity Nerve Growth Factor Receptor Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global High Affinity Nerve Growth Factor Receptor Market Size Market Share by Application (2017-2022)

3 High Affinity Nerve Growth Factor Receptor Market Size by Player

3.1 High Affinity Nerve Growth Factor Receptor Market Size Market Share by Players

3.1.1 Global High Affinity Nerve Growth Factor Receptor Revenue by Players (2020-2022)

3.1.2 Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Players (2020-2022)

3.2 Global High Affinity Nerve Growth Factor Receptor Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 High Affinity Nerve Growth Factor Receptor by Regions

4.1 High Affinity Nerve Growth Factor Receptor Market Size by Regions (2017-2022)

4.2 Americas High Affinity Nerve Growth Factor Receptor Market Size Growth (2017-2022)

4.3 APAC High Affinity Nerve Growth Factor Receptor Market Size Growth (2017-2022)

4.4 Europe High Affinity Nerve Growth Factor Receptor Market Size Growth (2017-2022)

4.5 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size Growth (2017-2022)

5 Americas

5.1 Americas High Affinity Nerve Growth Factor Receptor Market Size by Country (2017-2022)

5.2 Americas High Affinity Nerve Growth Factor Receptor Market Size by Type (2017-2022)

5.3 Americas High Affinity Nerve Growth Factor Receptor Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC High Affinity Nerve Growth Factor Receptor Market Size by Region (2017-2022)

6.2 APAC High Affinity Nerve Growth Factor Receptor Market Size by Type (2017-2022)

6.3 APAC High Affinity Nerve Growth Factor Receptor Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe High Affinity Nerve Growth Factor Receptor by Country (2017-2022)

7.2 Europe High Affinity Nerve Growth Factor Receptor Market Size by Type (2017-2022)

7.3 Europe High Affinity Nerve Growth Factor Receptor Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa High Affinity Nerve Growth Factor Receptor by Region (2017-2022)

8.2 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Type (2017-2022)

8.3 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global High Affinity Nerve Growth Factor Receptor Market Forecast

10.1 Global High Affinity Nerve Growth Factor Receptor Forecast by Regions (2023-2028)

10.1.1 Global High Affinity Nerve Growth Factor Receptor Forecast by Regions (2023-2028)

10.1.2 Americas High Affinity Nerve Growth Factor Receptor Forecast

10.1.3 APAC High Affinity Nerve Growth Factor Receptor Forecast

10.1.4 Europe High Affinity Nerve Growth Factor Receptor Forecast

10.1.5 Middle East & Africa High Affinity Nerve Growth Factor Receptor Forecast

10.2 Americas High Affinity Nerve Growth Factor Receptor Forecast by Country (2023-2028)

10.2.1 United States High Affinity Nerve Growth Factor Receptor Market Forecast

10.2.2 Canada High Affinity Nerve Growth Factor Receptor Market Forecast

10.2.3 Mexico High Affinity Nerve Growth Factor Receptor Market Forecast

10.2.4 Brazil High Affinity Nerve Growth Factor Receptor Market Forecast

10.3 APAC High Affinity Nerve Growth Factor Receptor Forecast by Region (2023-2028)

10.3.1 China High Affinity Nerve Growth Factor Receptor Market Forecast

10.3.2 Japan High Affinity Nerve Growth Factor Receptor Market Forecast

10.3.3 Korea High Affinity Nerve Growth Factor Receptor Market Forecast

10.3.4 Southeast Asia High Affinity Nerve Growth Factor Receptor Market Forecast

10.3.5 India High Affinity Nerve Growth Factor Receptor Market Forecast

10.3.6 Australia High Affinity Nerve Growth Factor Receptor Market Forecast

10.4 Europe High Affinity Nerve Growth Factor Receptor Forecast by Country (2023-2028)

10.4.1 Germany High Affinity Nerve Growth Factor Receptor Market Forecast

10.4.2 France High Affinity Nerve Growth Factor Receptor Market Forecast

10.4.3 UK High Affinity Nerve Growth Factor Receptor Market Forecast

10.4.4 Italy High Affinity Nerve Growth Factor Receptor Market Forecast

10.4.5 Russia High Affinity Nerve Growth Factor Receptor Market Forecast

10.5 Middle East & Africa High Affinity Nerve Growth Factor Receptor Forecast by Region (2023-2028)

10.5.1 Egypt High Affinity Nerve Growth Factor Receptor Market Forecast

10.5.2 South Africa High Affinity Nerve Growth Factor Receptor Market Forecast

10.5.3 Israel High Affinity Nerve Growth Factor Receptor Market Forecast

10.5.4 Turkey High Affinity Nerve Growth Factor Receptor Market Forecast

10.5.5 GCC Countries High Affinity Nerve Growth Factor Receptor Market Forecast

10.6 Global High Affinity Nerve Growth Factor Receptor Forecast by Type (2023-2028)

10.7 Global High Affinity Nerve Growth Factor Receptor Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Array BioPharma Inc

11.1.1 Array BioPharma Inc Company Information

11.1.2 Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Product Offered

11.1.3 Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Array BioPharma Inc Main Business Overview

11.1.5 Array BioPharma Inc Latest Developments

11.2 Astellas Pharma Inc

11.2.1 Astellas Pharma Inc Company Information

11.2.2 Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Product Offered

11.2.3 Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Astellas Pharma Inc Main Business Overview

11.2.5 Astellas Pharma Inc Latest Developments

11.3 AstraZeneca Plc

11.3.1 AstraZeneca Plc Company Information

11.3.2 AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Product Offered

11.3.3 AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 AstraZeneca Plc Main Business Overview

11.3.5 AstraZeneca Plc Latest Developments

11.4 Daiichi Sankyo Co Ltd

11.4.1 Daiichi Sankyo Co Ltd Company Information

11.4.2 Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Product Offered

11.4.3 Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Daiichi Sankyo Co Ltd Main Business Overview

11.4.5 Daiichi Sankyo Co Ltd Latest Developments

11.5 Dompe Farmaceutici SpA

11.5.1 Dompe Farmaceutici SpA Company Information

11.5.2 Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Product Offered

11.5.3 Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Dompe Farmaceutici SpA Main Business Overview

11.5.5 Dompe Farmaceutici SpA Latest Developments

11.6 Genzyme Corp

11.6.1 Genzyme Corp Company Information

11.6.2 Genzyme Corp High Affinity Nerve Growth Factor Receptor Product Offered

11.6.3 Genzyme Corp High Affinity Nerve Growth Factor Receptor Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Genzyme Corp Main Business Overview

11.6.5 Genzyme Corp Latest Developments

11.7 Handok Inc

11.7.1 Handok Inc Company Information

11.7.2 Handok Inc High Affinity Nerve Growth Factor Receptor Product Offered

11.7.3 Handok Inc High Affinity Nerve Growth Factor Receptor Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Handok Inc Main Business Overview

11.7.5 Handok Inc Latest Developments

11.8 Ignyta Inc

11.8.1 Ignyta Inc Company Information

11.8.2 Ignyta Inc High Affinity Nerve Growth Factor Receptor Product Offered

11.8.3 Ignyta Inc High Affinity Nerve Growth Factor Receptor Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Ignyta Inc Main Business Overview

11.8.5 Ignyta Inc Latest Developments

11.9 Loxo Oncology Inc

11.9.1 Loxo Oncology Inc Company Information

11.9.2 Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Product Offered

11.9.3 Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Loxo Oncology Inc Main Business Overview

11.9.5 Loxo Oncology Inc Latest Developments

11.10 Merck & Co Inc

11.10.1 Merck & Co Inc Company Information

11.10.2 Merck & Co Inc High Affinity Nerve Growth Factor Receptor Product Offered

11.10.3 Merck & Co Inc High Affinity Nerve Growth Factor Receptor Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Merck & Co Inc Main Business Overview

11.10.5 Merck & Co Inc Latest Developments

11.11 Nerviano Medical Sciences Srl

11.11.1 Nerviano Medical Sciences Srl Company Information

11.11.2 Nerviano Medical Sciences Srl High Affinity Nerve Growth Factor Receptor Product Offered

11.11.3 Nerviano Medical Sciences Srl High Affinity Nerve Growth Factor Receptor Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Nerviano Medical Sciences Srl Main Business Overview

11.11.5 Nerviano Medical Sciences Srl Latest Developments

11.12 Plexxikon Inc

11.12.1 Plexxikon Inc Company Information

11.12.2 Plexxikon Inc High Affinity Nerve Growth Factor Receptor Product Offered

11.12.3 Plexxikon Inc High Affinity Nerve Growth Factor Receptor Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Plexxikon Inc Main Business Overview

11.12.5 Plexxikon Inc Latest Developments

11.13 Proximagen Ltd

11.13.1 Proximagen Ltd Company Information

11.13.2 Proximagen Ltd High Affinity Nerve Growth Factor Receptor Product Offered

11.13.3 Proximagen Ltd High Affinity Nerve Growth Factor Receptor Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Proximagen Ltd Main Business Overview

11.13.5 Proximagen Ltd Latest Developments

11.14 Rottapharm Biotech Srl

11.14.1 Rottapharm Biotech Srl Company Information

11.14.2 Rottapharm Biotech Srl High Affinity Nerve Growth Factor Receptor Product Offered

11.14.3 Rottapharm Biotech Srl High Affinity Nerve Growth Factor Receptor Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Rottapharm Biotech Srl Main Business Overview

11.14.5 Rottapharm Biotech Srl Latest Developments

11.15 Sienna Biopharmaceuticals Inc

11.15.1 Sienna Biopharmaceuticals Inc Company Information

11.15.2 Sienna Biopharmaceuticals Inc High Affinity Nerve Growth Factor Receptor Product Offered

11.15.3 Sienna Biopharmaceuticals Inc High Affinity Nerve Growth Factor Receptor Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Sienna Biopharmaceuticals Inc Main Business Overview

11.15.5 Sienna Biopharmaceuticals Inc Latest Developments

11.16 Tiziana Life Sciences Plc

11.16.1 Tiziana Life Sciences Plc Company Information

11.16.2 Tiziana Life Sciences Plc High Affinity Nerve Growth Factor Receptor Product Offered

11.16.3 Tiziana Life Sciences Plc High Affinity Nerve Growth Factor Receptor Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Tiziana Life Sciences Plc Main Business Overview

11.16.5 Tiziana Life Sciences Plc Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. High Affinity Nerve Growth Factor Receptor Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of ASP-7962

Table 3. Major Players of AZD-7451

Table 4. Major Players of BNN-27

Table 5. Major Players of Cenegermin

Table 6. Major Players of CRB-0089

Table 7. Major Players of Others

Table 8. High Affinity Nerve Growth Factor Receptor Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global High Affinity Nerve Growth Factor Receptor Market Size by Type (2017-2022) & ($ Millions)

Table 10. Global High Affinity Nerve Growth Factor Receptor Market Size Market Share by Type (2017-2022)

Table 11. High Affinity Nerve Growth Factor Receptor Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 12. Global High Affinity Nerve Growth Factor Receptor Market Size by Application (2017-2022) & ($ Millions)

Table 13. Global High Affinity Nerve Growth Factor Receptor Market Size Market Share by Application (2017-2022)

Table 14. Global High Affinity Nerve Growth Factor Receptor Revenue by Players (2020-2022) & ($ Millions)

Table 15. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Player (2020-2022)

Table 16. High Affinity Nerve Growth Factor Receptor Key Players Head office and Products Offered

Table 17. High Affinity Nerve Growth Factor Receptor Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 18. New Products and Potential Entrants

Table 19. Mergers & Acquisitions, Expansion

Table 20. Global High Affinity Nerve Growth Factor Receptor Market Size by Regions 2017-2022 & ($ Millions)

Table 21. Global High Affinity Nerve Growth Factor Receptor Market Size Market Share by Regions (2017-2022)

Table 22. Americas High Affinity Nerve Growth Factor Receptor Market Size by Country (2017-2022) & ($ Millions)

Table 23. Americas High Affinity Nerve Growth Factor Receptor Market Size Market Share by Country (2017-2022)

Table 24. Americas High Affinity Nerve Growth Factor Receptor Market Size by Type (2017-2022) & ($ Millions)

Table 25. Americas High Affinity Nerve Growth Factor Receptor Market Size Market Share by Type (2017-2022)

Table 26. Americas High Affinity Nerve Growth Factor Receptor Market Size by Application (2017-2022) & ($ Millions)

Table 27. Americas High Affinity Nerve Growth Factor Receptor Market Size Market Share by Application (2017-2022)

Table 28. APAC High Affinity Nerve Growth Factor Receptor Market Size by Region (2017-2022) & ($ Millions)

Table 29. APAC High Affinity Nerve Growth Factor Receptor Market Size Market Share by Region (2017-2022)

Table 30. APAC High Affinity Nerve Growth Factor Receptor Market Size by Type (2017-2022) & ($ Millions)

Table 31. APAC High Affinity Nerve Growth Factor Receptor Market Size Market Share by Type (2017-2022)

Table 32. APAC High Affinity Nerve Growth Factor Receptor Market Size by Application (2017-2022) & ($ Millions)

Table 33. APAC High Affinity Nerve Growth Factor Receptor Market Size Market Share by Application (2017-2022)

Table 34. Europe High Affinity Nerve Growth Factor Receptor Market Size by Country (2017-2022) & ($ Millions)

Table 35. Europe High Affinity Nerve Growth Factor Receptor Market Size Market Share by Country (2017-2022)

Table 36. Europe High Affinity Nerve Growth Factor Receptor Market Size by Type (2017-2022) & ($ Millions)

Table 37. Europe High Affinity Nerve Growth Factor Receptor Market Size Market Share by Type (2017-2022)

Table 38. Europe High Affinity Nerve Growth Factor Receptor Market Size by Application (2017-2022) & ($ Millions)

Table 39. Europe High Affinity Nerve Growth Factor Receptor Market Size Market Share by Application (2017-2022)

Table 40. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Region (2017-2022) & ($ Millions)

Table 41. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size Market Share by Region (2017-2022)

Table 42. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Type (2017-2022) & ($ Millions)

Table 43. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size Market Share by Type (2017-2022)

Table 44. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Application (2017-2022) & ($ Millions)

Table 45. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size Market Share by Application (2017-2022)

Table 46. Key Market Drivers & Growth Opportunities of High Affinity Nerve Growth Factor Receptor

Table 47. Key Market Challenges & Risks of High Affinity Nerve Growth Factor Receptor

Table 48. Key Industry Trends of High Affinity Nerve Growth Factor Receptor

Table 49. Global High Affinity Nerve Growth Factor Receptor Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 50. Global High Affinity Nerve Growth Factor Receptor Market Size Market Share Forecast by Regions (2023-2028)

Table 51. Global High Affinity Nerve Growth Factor Receptor Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 52. Global High Affinity Nerve Growth Factor Receptor Market Size Market Share Forecast by Type (2023-2028)

Table 53. Global High Affinity Nerve Growth Factor Receptor Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 54. Global High Affinity Nerve Growth Factor Receptor Market Size Market Share Forecast by Application (2023-2028)

Table 55. Array BioPharma Inc Details, Company Type, High Affinity Nerve Growth Factor Receptor Area Served and Its Competitors

Table 56. Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Product Offered

Table 57. Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 58. Array BioPharma Inc Main Business

Table 59. Array BioPharma Inc Latest Developments

Table 60. Astellas Pharma Inc Details, Company Type, High Affinity Nerve Growth Factor Receptor Area Served and Its Competitors

Table 61. Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Product Offered

Table 62. Astellas Pharma Inc Main Business

Table 63. Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 64. Astellas Pharma Inc Latest Developments

Table 65. AstraZeneca Plc Details, Company Type, High Affinity Nerve Growth Factor Receptor Area Served and Its Competitors

Table 66. AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Product Offered

Table 67. AstraZeneca Plc Main Business

Table 68. AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 69. AstraZeneca Plc Latest Developments

Table 70. Daiichi Sankyo Co Ltd Details, Company Type, High Affinity Nerve Growth Factor Receptor Area Served and Its Competitors

Table 71. Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Product Offered

Table 72. Daiichi Sankyo Co Ltd Main Business

Table 73. Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 74. Daiichi Sankyo Co Ltd Latest Developments

Table 75. Dompe Farmaceutici SpA Details, Company Type, High Affinity Nerve Growth Factor Receptor Area Served and Its Competitors

Table 76. Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Product Offered

Table 77. Dompe Farmaceutici SpA Main Business

Table 78. Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 79. Dompe Farmaceutici SpA Latest Developments

Table 80. Genzyme Corp Details, Company Type, High Affinity Nerve Growth Factor Receptor Area Served and Its Competitors

Table 81. Genzyme Corp High Affinity Nerve Growth Factor Receptor Product Offered

Table 82. Genzyme Corp Main Business

Table 83. Genzyme Corp High Affinity Nerve Growth Factor Receptor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 84. Genzyme Corp Latest Developments

Table 85. Handok Inc Details, Company Type, High Affinity Nerve Growth Factor Receptor Area Served and Its Competitors

Table 86. Handok Inc High Affinity Nerve Growth Factor Receptor Product Offered

Table 87. Handok Inc Main Business

Table 88. Handok Inc High Affinity Nerve Growth Factor Receptor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 89. Handok Inc Latest Developments

Table 90. Ignyta Inc Details, Company Type, High Affinity Nerve Growth Factor Receptor Area Served and Its Competitors

Table 91. Ignyta Inc High Affinity Nerve Growth Factor Receptor Product Offered

Table 92. Ignyta Inc Main Business

Table 93. Ignyta Inc High Affinity Nerve Growth Factor Receptor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 94. Ignyta Inc Latest Developments

Table 95. Loxo Oncology Inc Details, Company Type, High Affinity Nerve Growth Factor Receptor Area Served and Its Competitors

Table 96. Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Product Offered

Table 97. Loxo Oncology Inc Main Business

Table 98. Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 99. Loxo Oncology Inc Latest Developments

Table 100. Merck & Co Inc Details, Company Type, High Affinity Nerve Growth Factor Receptor Area Served and Its Competitors

Table 101. Merck & Co Inc High Affinity Nerve Growth Factor Receptor Product Offered

Table 102. Merck & Co Inc Main Business

Table 103. Merck & Co Inc High Affinity Nerve Growth Factor Receptor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Merck & Co Inc Latest Developments

Table 105. Nerviano Medical Sciences Srl Details, Company Type, High Affinity Nerve Growth Factor Receptor Area Served and Its Competitors

Table 106. Nerviano Medical Sciences Srl High Affinity Nerve Growth Factor Receptor Product Offered

Table 107. Nerviano Medical Sciences Srl High Affinity Nerve Growth Factor Receptor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 108. Nerviano Medical Sciences Srl Main Business

Table 109. Nerviano Medical Sciences Srl Latest Developments

Table 110. Plexxikon Inc Details, Company Type, High Affinity Nerve Growth Factor Receptor Area Served and Its Competitors

Table 111. Plexxikon Inc High Affinity Nerve Growth Factor Receptor Product Offered

Table 112. Plexxikon Inc Main Business

Table 113. Plexxikon Inc High Affinity Nerve Growth Factor Receptor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 114. Plexxikon Inc Latest Developments

Table 115. Proximagen Ltd Details, Company Type, High Affinity Nerve Growth Factor Receptor Area Served and Its Competitors

Table 116. Proximagen Ltd High Affinity Nerve Growth Factor Receptor Product Offered

Table 117. Proximagen Ltd Main Business

Table 118. Proximagen Ltd High Affinity Nerve Growth Factor Receptor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 119. Proximagen Ltd Latest Developments

Table 120. Rottapharm Biotech Srl Details, Company Type, High Affinity Nerve Growth Factor Receptor Area Served and Its Competitors

Table 121. Rottapharm Biotech Srl High Affinity Nerve Growth Factor Receptor Product Offered

Table 122. Rottapharm Biotech Srl Main Business

Table 123. Rottapharm Biotech Srl High Affinity Nerve Growth Factor Receptor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 124. Rottapharm Biotech Srl Latest Developments

Table 125. Sienna Biopharmaceuticals Inc Details, Company Type, High Affinity Nerve Growth Factor Receptor Area Served and Its Competitors

Table 126. Sienna Biopharmaceuticals Inc High Affinity Nerve Growth Factor Receptor Product Offered

Table 127. Sienna Biopharmaceuticals Inc Main Business

Table 128. Sienna Biopharmaceuticals Inc High Affinity Nerve Growth Factor Receptor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 129. Sienna Biopharmaceuticals Inc Latest Developments

Table 130. Tiziana Life Sciences Plc Details, Company Type, High Affinity Nerve Growth Factor Receptor Area Served and Its Competitors

Table 131. Tiziana Life Sciences Plc High Affinity Nerve Growth Factor Receptor Product Offered

Table 132. Tiziana Life Sciences Plc Main Business

Table 133. Tiziana Life Sciences Plc High Affinity Nerve Growth Factor Receptor Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 134. Tiziana Life Sciences Plc Latest Developments

List of Figures

Figure 1. High Affinity Nerve Growth Factor Receptor Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global High Affinity Nerve Growth Factor Receptor Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global High Affinity Nerve Growth Factor Receptor Market Size Market Share by Type in 2021

Figure 7. High Affinity Nerve Growth Factor Receptor in Bile Duct Cancer

Figure 8. Global High Affinity Nerve Growth Factor Receptor Market: Bile Duct Cancer (2017-2022) & ($ Millions)

Figure 9. High Affinity Nerve Growth Factor Receptor in Papillary Thyroid Cancer

Figure 10. Global High Affinity Nerve Growth Factor Receptor Market: Papillary Thyroid Cancer (2017-2022) & ($ Millions)

Figure 11. High Affinity Nerve Growth Factor Receptor in Low Back Pain

Figure 12. Global High Affinity Nerve Growth Factor Receptor Market: Low Back Pain (2017-2022) & ($ Millions)

Figure 13. High Affinity Nerve Growth Factor Receptor in Lung Cancer

Figure 14. Global High Affinity Nerve Growth Factor Receptor Market: Lung Cancer (2017-2022) & ($ Millions)

Figure 15. High Affinity Nerve Growth Factor Receptor in Others

Figure 16. Global High Affinity Nerve Growth Factor Receptor Market: Others (2017-2022) & ($ Millions)

Figure 17. Global High Affinity Nerve Growth Factor Receptor Market Size Market Share by Application in 2021

Figure 18. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Player in 2021

Figure 19. Global High Affinity Nerve Growth Factor Receptor Market Size Market Share by Regions (2017-2022)

Figure 20. Americas High Affinity Nerve Growth Factor Receptor Market Size 2017-2022 ($ Millions)

Figure 21. APAC High Affinity Nerve Growth Factor Receptor Market Size 2017-2022 ($ Millions)

Figure 22. Europe High Affinity Nerve Growth Factor Receptor Market Size 2017-2022 ($ Millions)

Figure 23. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size 2017-2022 ($ Millions)

Figure 24. Americas High Affinity Nerve Growth Factor Receptor Value Market Share by Country in 2021

Figure 25. Americas High Affinity Nerve Growth Factor Receptor Consumption Market Share by Type in 2021

Figure 26. Americas High Affinity Nerve Growth Factor Receptor Market Size Market Share by Application in 2021

Figure 27. United States High Affinity Nerve Growth Factor Receptor Market Size Growth 2017-2022 ($ Millions)

Figure 28. Canada High Affinity Nerve Growth Factor Receptor Market Size Growth 2017-2022 ($ Millions)

Figure 29. Mexico High Affinity Nerve Growth Factor Receptor Market Size Growth 2017-2022 ($ Millions)

Figure 30. Brazil High Affinity Nerve Growth Factor Receptor Market Size Growth 2017-2022 ($ Millions)

Figure 31. APAC High Affinity Nerve Growth Factor Receptor Market Size Market Share by Region in 2021

Figure 32. APAC High Affinity Nerve Growth Factor Receptor Market Size Market Share by Application in 2021

Figure 33. China High Affinity Nerve Growth Factor Receptor Market Size Growth 2017-2022 ($ Millions)

Figure 34. Japan High Affinity Nerve Growth Factor Receptor Market Size Growth 2017-2022 ($ Millions)

Figure 35. Korea High Affinity Nerve Growth Factor Receptor Market Size Growth 2017-2022 ($ Millions)

Figure 36. Southeast Asia High Affinity Nerve Growth Factor Receptor Market Size Growth 2017-2022 ($ Millions)

Figure 37. India High Affinity Nerve Growth Factor Receptor Market Size Growth 2017-2022 ($ Millions)

Figure 38. Australia High Affinity Nerve Growth Factor Receptor Market Size Growth 2017-2022 ($ Millions)

Figure 39. Europe High Affinity Nerve Growth Factor Receptor Market Size Market Share by Country in 2021

Figure 40. Europe High Affinity Nerve Growth Factor Receptor Market Size Market Share by Type in 2021

Figure 41. Europe High Affinity Nerve Growth Factor Receptor Market Size Market Share by Application in 2021

Figure 42. Germany High Affinity Nerve Growth Factor Receptor Market Size Growth 2017-2022 ($ Millions)

Figure 43. France High Affinity Nerve Growth Factor Receptor Market Size Growth 2017-2022 ($ Millions)

Figure 44. UK High Affinity Nerve Growth Factor Receptor Market Size Growth 2017-2022 ($ Millions)

Figure 45. Italy High Affinity Nerve Growth Factor Receptor Market Size Growth 2017-2022 ($ Millions)

Figure 46. Russia High Affinity Nerve Growth Factor Receptor Market Size Growth 2017-2022 ($ Millions)

Figure 47. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size Market Share by Region in 2021

Figure 48. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size Market Share by Type in 2021

Figure 49. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size Market Share by Application in 2021

Figure 50. Egypt High Affinity Nerve Growth Factor Receptor Market Size Growth 2017-2022 ($ Millions)

Figure 51. South Africa High Affinity Nerve Growth Factor Receptor Market Size Growth 2017-2022 ($ Millions)

Figure 52. Israel High Affinity Nerve Growth Factor Receptor Market Size Growth 2017-2022 ($ Millions)

Figure 53. Turkey High Affinity Nerve Growth Factor Receptor Market Size Growth 2017-2022 ($ Millions)

Figure 54. GCC Country High Affinity Nerve Growth Factor Receptor Market Size Growth 2017-2022 ($ Millions)

Figure 55. Americas High Affinity Nerve Growth Factor Receptor Market Size 2023-2028 ($ Millions)

Figure 56. APAC High Affinity Nerve Growth Factor Receptor Market Size 2023-2028 ($ Millions)

Figure 57. Europe High Affinity Nerve Growth Factor Receptor Market Size 2023-2028 ($ Millions)

Figure 58. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size 2023-2028 ($ Millions)

Figure 59. United States High Affinity Nerve Growth Factor Receptor Market Size 2023-2028 ($ Millions)

Figure 60. Canada High Affinity Nerve Growth Factor Receptor Market Size 2023-2028 ($ Millions)

Figure 61. Mexico High Affinity Nerve Growth Factor Receptor Market Size 2023-2028 ($ Millions)

Figure 62. Brazil High Affinity Nerve Growth Factor Receptor Market Size 2023-2028 ($ Millions)

Figure 63. China High Affinity Nerve Growth Factor Receptor Market Size 2023-2028 ($ Millions)

Figure 64. Japan High Affinity Nerve Growth Factor Receptor Market Size 2023-2028 ($ Millions)

Figure 65. Korea High Affinity Nerve Growth Factor Receptor Market Size 2023-2028 ($ Millions)

Figure 66. Southeast Asia High Affinity Nerve Growth Factor Receptor Market Size 2023-2028 ($ Millions)

Figure 67. India High Affinity Nerve Growth Factor Receptor Market Size 2023-2028 ($ Millions)

Figure 68. Australia High Affinity Nerve Growth Factor Receptor Market Size 2023-2028 ($ Millions)

Figure 69. Germany High Affinity Nerve Growth Factor Receptor Market Size 2023-2028 ($ Millions)

Figure 70. France High Affinity Nerve Growth Factor Receptor Market Size 2023-2028 ($ Millions)

Figure 71. UK High Affinity Nerve Growth Factor Receptor Market Size 2023-2028 ($ Millions)

Figure 72. Italy High Affinity Nerve Growth Factor Receptor Market Size 2023-2028 ($ Millions)

Figure 73. Russia High Affinity Nerve Growth Factor Receptor Market Size 2023-2028 ($ Millions)

Figure 74. Spain High Affinity Nerve Growth Factor Receptor Market Size 2023-2028 ($ Millions)

Figure 75. Egypt High Affinity Nerve Growth Factor Receptor Market Size 2023-2028 ($ Millions)

Figure 76. South Africa High Affinity Nerve Growth Factor Receptor Market Size 2023-2028 ($ Millions)

Figure 77. Israel High Affinity Nerve Growth Factor Receptor Market Size 2023-2028 ($ Millions)

Figure 78. Turkey High Affinity Nerve Growth Factor Receptor Market Size 2023-2028 ($ Millions)

Figure 79. GCC Countries High Affinity Nerve Growth Factor Receptor Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390